Secor Capital Advisors’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-20,574
| Closed | -$691K | – | 347 |
|
|
2018
Q4 | $691K | Buy |
+20,574
| New | +$691K | 0.09% | 225 |
|
|
2017
Q1 | – | Sell |
-46,984
| Closed | -$2.3M | – | 377 |
|
|
2016
Q4 | $2.3M | Sell |
46,984
-21,460
| -31% | -$1.05M | 0.28% | 90 |
|
|
2016
Q3 | $3.28M | Buy |
68,444
+39,884
| +140% | +$1.91M | 0.36% | 73 |
|
|
2016
Q2 | $1.53M | Buy |
28,560
+14,286
| +100% | +$766K | 0.19% | 126 |
|
|
2016
Q1 | $638K | Sell |
14,274
-8,534
| -37% | -$381K | 0.09% | 222 |
|
|
2015
Q4 | $870K | Buy |
+22,808
| New | +$870K | 0.25% | 117 |
|
|
2015
Q3 | – | Sell |
-18,065
| Closed | -$597K | – | 447 |
|
|
2015
Q2 | $597K | Buy |
+18,065
| New | +$597K | 0.21% | 172 |
|
|
2014
Q1 | – | Sell |
-15,871
| Closed | -$606K | – | 277 |
|
|
2013
Q4 | $606K | Buy |
+15,871
| New | +$606K | 0.24% | 175 |
|